Package 72205-170-72

{"route": ["ORAL"], "spl_id": "3efa1e5e-5a14-4724-a2ca-25702f10faed", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0372205170728"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["3efa1e5e-5a14-4724-a2ca-25702f10faed"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (72205-170-72)", "package_ndc": "72205-170-72", "marketing_start_date": "20231023"}], "brand_name": "Acyclovir suspension", "product_id": "72205-170_3efa1e5e-5a14-4724-a2ca-25702f10faed", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72205-170", "generic_name": "Acyclovir", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir suspension", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA217393", "marketing_category": "ANDA", "marketing_start_date": "20230309", "listing_expiration_date": "20261231"}